Arthur Morgan, who is five months old, was given the potentially life-saving one-off gene therapy called Zolgensma
A five-month-old baby has become the first patient in England treated with a potentially life-saving drug on the NHS that can prolong the lives of children with spinal muscular atrophy.
Arthur Morgan, who was diagnosed with the condition earlier this month, received the one-off gene therapy at Evelina London children’s hospital on 25 May.
